The future of patient-centered oncology care in Bulgaria: round table

7 November 2016
cancerbig

Around table conference on “The Future of Patient-Centered Oncology Care in Bulgaria” was held last month at the National Assembly of the Republic of Bulgaria.

Comparator Report on Patient Access to Cancer Medicines in Europe 2016was presented for the first time in Bulgaria by one of its authors – Dr Nils Wilking from Karolinska Institute, based in Stockholm. The discussion was attended by leading experts in the field of oncology, representatives of institutions and patient organizations, reported the trade group the Association of the Research-based Pharmaceutical Manufacturers in Bulgaria (ARPharM).

The participants agreed that the treatment of oncological diseases is at a turning point with treatments providing better outcomes for the individual patient and at macro-level, for society as a whole. Advancements in both the cutting-edge science and the treatment outcomes are changing the profile of cancer from life-threatening to chronic disease, transforming cancer care and most importantly increasing the proportion of cancer survivors.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical